JenaValve Technology Receives CE Mark for its Trilogy™ TAVI System for the Treatment of Aortic Regurgitation and Aortic Stenosis
May 25, 2021 08:00 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation (TAVI) systems (also referred to as...
JenaValve Technology Welcomes Jane Metcalf as Vice President, Regulatory Affairs and Quality
March 18, 2021 16:02 ET
|
JenaValve Technology, Inc.
IRVINE, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of differentiated pericardial transcatheter aortic valve replacement (TAVR) systems for the...